Abstract:Post-stroke cognitive impairment (PSCI) is a major stroke consequence that has a severe impact on patients' quality of life and survival rate. For this reason, it is especially crucial to identify and intervene early in high-risk groups during the acute phase of stroke. Currently, there are no reliable and efficient techniques for the early diagnosis, appropriate evaluation, or prognostication of PSCI. Instead, plenty of biomarkers in stroke patients have progressively been linked to cognitive impairment in recent years. High-throughput omics techniques that generate large amounts of data and process it to a high quality have been used to screen and identify biomarkers of PSCI in order to investigate the molecular mechanisms of the disease. These techniques include metabolomics, which explores dynamic changes in the organism, gut microbiomics, which studies host–microbe interactions, genomics, which elucidates deeper disease mechanisms, transcriptomics and proteomics, which describe gene expression and regulation. We looked through electronic databases like PubMed, the Cochrane Library, Embase, Web of Science, and common databases for each omics to find biomarkers that might be connected to the pathophysiology of PSCI. As all, we found 34 studies: 14 in the field of metabolomics, 5 in the field of gut microbiomics, 5 in the field of genomics, 4 in the field of transcriptomics, and 7 in the field of proteomics. We discovered that neuroinflammation, oxidative stress, and atherosclerosis may be the primary causes of PSCI development, and that metabolomics may play a role in the molecular mechanisms of PSCI. In this study, we summarized the existing issues across omics technologies and discuss the latest discoveries of PSCI biomarkers in the context of omics, with the goal of investigating the molecular causes of post-stroke cognitive impairment. We also discuss the potential therapeutic utility of omics platforms for PSCI mechanisms, diagnosis, and intervention in order to promote the area's advancement towards precision PSCI treatment.

Research Progress of Inflammatory Biomarkers in Patients with Post-stroke Cognitive Impairment

Imaging Markers in Acute Phase of Stroke: Implications for Prognosis

Advances in Serological Biomarkers and Imaging to Predict Post-Stroke Cognitive Impairment

Blood biomarkers for post-stroke cognitive impairment: A systematic review and meta-analysis

Inflammation, Anti-inflammatory Interventions, and Post-stroke Cognitive Impairment: a Systematic Review and Meta-analysis of Human and Animal Studies

Potential Biomarkers for Post-Stroke Cognitive Impairment: A Systematic Review and Meta-Analysis

Progress in the nursing of post-stroke cognitive impairment

Post-stroke cognitive impairment: exploring molecular mechanisms and omics biomarkers for early identification and intervention

Association between Systemic Immune Inflammation Index and Cognitive Impairment after Acute Ischemic Stroke

Update on the mechanism of microglia involvement in post-stroke cognitive impairment

Pathological Mechanism and Drug Therapy for Post Stroke Depression

Effect of Inflammation on the Process of Stroke Rehabilitation and Poststroke Depression

Research on Diagnostic Markers for Post-Stroke Cognitive Impairment.

Early biomarkers for post-stroke cognitive impairment

Prediction of poststroke cognitive impairment based on the systemic inflammatory response index

Inflammatory markers as independent predictors for stroke outcomes

Inflammatory biomarkers in blood of patients with acute brain ischemia

Inflammation-Derived and Clinical Indicator-Based Predictive Model for Ischemic Stroke Recovery

Systemic inflammation response index as a clinical outcome evaluating tool and prognostic indicator for hospitalized stroke patients: a systematic review and meta-analysis

Biomarkers and the outcomes of ischemic stroke

Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management.